Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Am J Cardiol ; 114(5): 777-82, 2014 Sep 01.
Article in English | MEDLINE | ID: mdl-25037678

ABSTRACT

Apical hypertrophic cardiomyopathy (HC) is an uncommon variant of HC. We sought to characterize cardiac magnetic resonance imaging (MRI) findings among apical HC patients. This was a retrospective review of consecutive patients with a diagnosis of apical HC who underwent cardiac MRI examinations at the Mayo Clinic (Rochester, MN) from August 1999 to October 2011. Clinical and demographic data at the time of cardiac MRI study were abstracted. Cardiac MRI study and 2-dimensional echocardiograms performed within 6 months of the cardiac MRI were reviewed; 96 patients with apical HC underwent cardiac MRI examinations. LV end-diastolic and end-systolic volumes were 130.7 ± 39.1 ml and 44.2 ± 20.9 ml, respectively. Maximum LV thickness was 19 ± 5 mm. Hypertrophy extended beyond the apex into other segments in 57 (59.4%) patients. Obstructive physiology was seen in 12 (12.5%) and was more common in the mixed apical phenotype than the pure apical (19.3 vs 2.6%, p = 0.02). Apical pouches were noted in 39 (40.6%) patients. Late gadolinium enhancement (LGE) was present in 70 (74.5%) patients. LGE was associated with severe symptoms and increased maximal LV wall thickness. In conclusion, cardiac MRI is well suited for studying the apical form of HC because of difficulty imaging the cardiac apex with standard echocardiography. Cardiac MRI is uniquely suited to delineate the presence or absence of an apical pouch and abnormal myocardial LGE that may have implications in the natural history of apical HM. In particular, the presence of abnormal LGE is associated with clinical symptoms and increased wall thickness.


Subject(s)
Cardiomyopathy, Hypertrophic/diagnosis , Gadolinium DTPA , Magnetic Resonance Imaging, Cine/methods , Contrast Media , Electrocardiography, Ambulatory , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prognosis , Reproducibility of Results , Retrospective Studies
2.
Mayo Clin Proc ; 89(8): 1143-52, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24997091

ABSTRACT

The objective of this review was to describe the clinical characteristics, risk factors, and outcomes of infective endocarditis (IE) in pregnancy and the postpartum period. We conducted a systematic review of Ovid MEDLINE, Ovid Embase, Web of Science, and Scopus from January 1, 1988, through October 31, 2012. Included studies reported on women who met the modified Duke criteria for the diagnosis of IE and were pregnant or postpartum. We included 72 studies that described 90 cases of peripartum IE, mostly affecting native valves (92%). Risk factors associated with IE included intravenous drug use (14%), congenital heart disease (12%), and rheumatic heart disease (12%). The most common pathogens were streptococcal (43%) and staphylococcal (26%) species. Septic pulmonary, central, and other systemic emboli were common complications. Of the 51 pregnancies, there were 41 (80%) deliveries with survival to discharge, 7 (14%) fetal deaths, 1 (2%) medical termination of pregnancy, and 2 (4%) with unknown status. Maternal mortality was 11%. Infective endocarditis is a rare, life-threatening infection in pregnancy. Risk factors are changing with a marked decrease in rheumatic heart disease and an increase in intravenous drug use. The cases reported in the literature were commonly due to streptococcal organisms, involved the right-sided valves, and were associated with intravenous drug use.


Subject(s)
Endocarditis, Bacterial/mortality , Pregnancy Complications, Cardiovascular/mortality , Pregnancy Complications, Infectious/mortality , Pregnancy Outcome , Adult , Endocarditis, Bacterial/etiology , Endocarditis, Bacterial/microbiology , Female , Heart Defects, Congenital/complications , Heart Defects, Congenital/microbiology , Humans , Infant Mortality , Infant, Newborn , Maternal Mortality , Peripartum Period , Pregnancy , Pregnancy Complications, Cardiovascular/etiology , Pregnancy Complications, Cardiovascular/microbiology , Pregnancy Complications, Infectious/etiology , Pregnancy Complications, Infectious/microbiology , Rheumatic Heart Disease/complications , Rheumatic Heart Disease/microbiology , Risk Factors , Substance Abuse, Intravenous/complications , Substance Abuse, Intravenous/microbiology
3.
Int J Cardiovasc Imaging ; 30(3): 591-7, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24390362

ABSTRACT

The presence of apical pouches in hypertrophic cardiomyopathy (HCM) may portend poor prognosis. We sought to study if the use cardiac magnetic resonance imaging (CMR) improves the detection of apical pouches in HCM compared to echocardiography. A retrospective review was performed of all consecutive HCM patients with an apical pouch identified by CMR at Mayo Clinic from May 2004 to Sept 2011. Clinical data was abstracted and CMR and echocardiographic images were analyzed. There were 56 consecutive HCM patients with an apical pouch identified by CMR. The predominant morphological type was apical in 41 (73.2 %), followed by sigmoid in 6 (10.7 %), reversed curve in 6 (10.7 %) and neutral in 3 (5.4 %). Obstructive physiology or systolic anterior motion of the mitral valve leaflet was evident in 23 (41.1 %). Late gadolinium enhancement was present in 47 (87.0 %) patients. Apical pouches were detected in only 18 (32.1 %) patients on echocardiography. Even when intravenous contrast was used (29/56 patients), in 16/29 (55.2 %) pouches were missed on echocardiography. Pouch length and neck dimensions in systole and diastole, measured on CMR, were larger among those patients in whom pouches were detected on echocardiography suggesting only larger pouches can be identified on echocardiography. In the largest CMR series to date of apical pouches in HCM, we show that while apical pouches are most commonly seen in apical HCM, they can be found in other phenotypic variants. CMR is better suited for the evaluation of apical pouches compared to echocardiography even with the use of intravenous contrast. CMR is likely a better tool for evaluating the cardiac apical structures including apical pouches when clinically indicated.


Subject(s)
Cardiomyopathy, Hypertrophic/pathology , Magnetic Resonance Imaging/methods , Myocardium/pathology , Cardiomyopathy, Hypertrophic/diagnostic imaging , Contrast Media , Female , Gadolinium , Humans , Image Enhancement/methods , Male , Middle Aged , Retrospective Studies , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL
...